bendamustine (treanda) Report issue

Small molecule Orphan Drug FDA Approved FDA Priority Review FDA
Back

Drug Pricing Summary

AUS PBS

$156.4788 - $625.9152

VA Big4

$485.4900 - $1922.6200

VA FSS

$731.7500 - $2926.9900

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
bendamustine 25 mg (INJECTION) $156.4788 AUS PBS generic
  • Ribomustin (1)
  • Janssen-Cilag Pty Ltd
    bendamustine hydrochloride 100 mg (INJECTION) $625.9152 AUS PBS generic
  • Ribomustin (1)
  • Janssen-Cilag Pty Ltd
    bendamustine hydrochloride 100 mg / 20 mL (20 mL INJECTION) $1922.6200 VA Big4
  • TREANDA (1)
  • Teva Pharmaceuticals USA, Inc.
    bendamustine hydrochloride 100 mg / 20 mL (20 mL INJECTION) $2926.9900 VA FSS
  • TREANDA (1)
  • Teva Pharmaceuticals USA, Inc.
    bendamustine hydrochloride 25 mg / 1 mL (1 mL INJECTION) $1562.9500 VA Big4
  • Bendeka (1)
  • Teva Pharmaceuticals USA, Inc.
    bendamustine hydrochloride 25 mg / 1 mL (1 mL INJECTION) $2051.1500 VA FSS
  • Bendeka (1)
  • Teva Pharmaceuticals USA, Inc.
    bendamustine hydrochloride 25 mg / 5 mL (5 mL INJECTION) $485.4900 VA Big4
  • TREANDA (1)
  • Teva Pharmaceuticals USA, Inc.
    bendamustine hydrochloride 25 mg / 5 mL (5 mL INJECTION) $731.7500 VA FSS
  • TREANDA (1)
  • Teva Pharmaceuticals USA, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue